Clinical Trial

Effects of the Consumption of Test Product on Urination in Healthy Japanese Adults

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 6, 2026 (before its estimated June 19, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to test in Japanese adults who experience concerns regarding urinary frequency. The main question it aims to answer is: •Does consumption of Cranberry Phospholipids reduce daytime urinary frequency? Participants will be given the following tasks: * Take two tablets daily containing Cranberry Phospholipid for eight weeks. * Answer the questionnaire on the overactive bladder (OAB)-specific quality of life (QOL). * Answer the questionnaire on OAB symptoms. * Answer the questionnaire on urinary frequency during the study period. Researchers will compare Cranberry Phospholipids and placebo groups to see if Cranberry Phospholipids reduces daytime urinary frequency.
Trial Details
NCT Number NCT07393126
Lead Sponsor Indena S.p.A
Collaborators: Orthomedico Inc., Indena Japan Co. LTD
Conditions Healthy Japanese
Enrollment 76 participants
Start Date 2025-12-08
Primary Completion 2026-06-19 (estimated)
Study Completion 2026-06-19 (estimated)
Updated on ClinicalTrials.gov 2026-02-06